| FLL32 |
Influence on cell apoptosis |
Western Blot |
2.50 µM |
OSA8 |
Canis lupus |
|
|
|
| FLL32 |
Influence on cell apoptosis |
Western Blot |
7.50 µM |
OSA8 |
Canis lupus |
|
|
|
| FLL32 |
Influence on cell apoptosis |
Western Blot |
10.00 µM |
OSA8 |
Canis lupus |
|
|
|
| FLL32 |
Influence on cell apoptosis |
Western Blot |
2.50 µM |
OSA8 |
Canis lupus |
|
|
|
| FLL32 |
Influence on cell apoptosis |
Western Blot |
7.50 µM |
OSA8 |
Canis lupus |
|
|
|
| FLL32 |
Influence on cell apoptosis |
Western Blot |
10.00 µM |
OSA8 |
Canis lupus |
|
|
|
| FLL32 |
Influence on cell apoptosis |
Western Blot |
2.50 µM |
OSA16 |
Canis lupus |
|
|
|
| FLL32 |
Influence on cell apoptosis |
Western Blot |
7.50 µM |
OSA16 |
Canis lupus |
|
|
|
| FLL32 |
Influence on cell apoptosis |
Western Blot |
10.00 µM |
OSA16 |
Canis lupus |
|
|
|
| FLL32 |
Influence on cell apoptosis |
Western Blot |
2.50 µM |
OSA16 |
Canis lupus |
|
|
|
| FLL32 |
Influence on cell apoptosis |
Western Blot |
7.50 µM |
OSA16 |
Canis lupus |
|
|
|
| FLL32 |
Influence on cell apoptosis |
Western Blot |
10.00 µM |
OSA16 |
Canis lupus |
|
|
|
| FLL32 |
Influence on cell apoptosis |
Western Blot |
2.50 µM |
D17 |
Canis lupus |
|
|
|
| FLL32 |
Influence on cell apoptosis |
Western Blot |
7.50 µM |
D17 |
Canis lupus |
|
|
|
| FLL32 |
Influence on cell apoptosis |
Western Blot |
10.00 µM |
D17 |
Canis lupus |
|
|
|
| FLL32 |
Influence on cell apoptosis |
Western Blot |
2.50 µM |
D17 |
Canis lupus |
|
|
|
| FLL32 |
Influence on cell apoptosis |
Western Blot |
7.50 µM |
D17 |
Canis lupus |
|
|
|
| FLL32 |
Influence on cell apoptosis |
Western Blot |
10.00 µM |
D17 |
Canis lupus |
|
|
|
| FLL32 |
Influence on cell apoptosis |
Western Blot |
2.50 µM |
SJSA |
Homo sapiens |
|
|
|
| FLL32 |
Influence on cell apoptosis |
Western Blot |
7.50 µM |
SJSA |
Homo sapiens |
|
|
|
| FLL32 |
Influence on cell apoptosis |
Western Blot |
10.00 µM |
SJSA |
Homo sapiens |
|
|
|
| FLL32 |
Influence on cell apoptosis |
Western Blot |
2.50 µM |
SJSA |
Homo sapiens |
|
|
|
| FLL32 |
Influence on cell apoptosis |
Western Blot |
7.50 µM |
SJSA |
Homo sapiens |
|
|
|
| FLL32 |
Influence on cell apoptosis |
Western Blot |
10.00 µM |
SJSA |
Homo sapiens |
|
|
|
| FLL32 |
Influence on cell apoptosis |
Western Blot |
2.50 µM |
U2OS |
Homo sapiens |
|
|
|
| FLL32 |
Influence on cell apoptosis |
Western Blot |
7.50 µM |
U2OS |
Homo sapiens |
|
|
|
| FLL32 |
Influence on cell apoptosis |
Western Blot |
10.00 µM |
U2OS |
Homo sapiens |
|
|
|
| FLL32 |
Influence on cell apoptosis |
Western Blot |
2.50 µM |
U2OS |
Homo sapiens |
|
|
|
| FLL32 |
Influence on cell apoptosis |
Western Blot |
7.50 µM |
U2OS |
Homo sapiens |
|
|
|
| FLL32 |
Influence on cell apoptosis |
Western Blot |
10.00 µM |
U2OS |
Homo sapiens |
|
|
|
| FLL32 |
Influence on protein activity |
Western Blot |
2.00 µM |
A375 |
Homo sapiens |
|
|
|
| FLL32 |
Influence on protein activity |
Western Blot |
4.00 µM |
A375 |
Homo sapiens |
|
|
|
| FLL32 |
Influence on protein activity |
Western Blot |
2.00 µM |
Hs294T |
Homo sapiens |
|
|
|
| FLL32 |
Influence on protein activity |
Western Blot |
4.00 µM |
Hs294T |
Homo sapiens |
|
|
|
| FLL32 |
Influence on apoptosis |
Western Blot |
2.00 µM |
primary human cells derived from recurrent cutaneous
melanoma tumors |
Homo sapiens |
patient 1 |
|
|
| FLL32 |
Influence on apoptosis |
Western Blot |
4.00 µM |
primary human cells derived from recurrent cutaneous
melanoma tumors |
Homo sapiens |
patient 1 |
|
|
| FLL32 |
Influence on apoptosis |
Western Blot |
6.00 µM |
primary human cells derived from recurrent cutaneous
melanoma tumors |
Homo sapiens |
patient 1 |
|
|
| FLL32 |
Influence on apoptosis |
Western Blot |
8.00 µM |
primary human cells derived from recurrent cutaneous
melanoma tumors |
Homo sapiens |
patient 1 |
|
|
| FLL32 |
Influence on apoptosis |
Western Blot |
2.00 µM |
primary human cells derived from recurrent cutaneous
melanoma tumors |
Homo sapiens |
patient 2 |
|
|
| FLL32 |
Influence on apoptosis |
Western Blot |
4.00 µM |
primary human cells derived from recurrent cutaneous
melanoma tumors |
Homo sapiens |
patient 2 |
|
|
| FLL32 |
Influence on apoptosis |
Western Blot |
6.00 µM |
primary human cells derived from recurrent cutaneous
melanoma tumors |
Homo sapiens |
patient 2 |
|
|
| FLL32 |
Influence on apoptosis |
Western Blot |
8.00 µM |
primary human cells derived from recurrent cutaneous
melanoma tumors |
Homo sapiens |
patient 2 |
|
|
| FLL32 |
Influence on caspase dependent apoptosis in presence on caspase inhibitor |
Western Blot |
2.00 µM |
A375 |
Homo sapiens |
|
|
|
| FLL32 |
Influence on caspase dependent apoptosis in presence on caspase inhibitor |
Western Blot |
4.00 µM |
A375 |
Homo sapiens |
|
|
|
| FLL32 |
Influence on cell viabiliy |
Western Blot |
2.00 µM |
PBMC |
Homo sapiens |
|
|
|
| FLL32 |
Influence on cell viabiliy |
Western Blot |
4.00 µM |
PBMC |
Homo sapiens |
|
|
|
| FLL32 |
Influence on cell viabiliy |
Western Blot |
6.00 µM |
PBMC |
Homo sapiens |
|
|
|
| FLL32 |
Influence on cell viabiliy |
Western Blot |
8.00 µM |
PBMC |
Homo sapiens |
|
|
|
| FLL32 |
Influence on cell viabiliy |
Western Blot |
10.00 µM |
PBMC |
Homo sapiens |
|
|
|
| FLL32 |
Influence on protein activity |
Western Blot |
5.00 µM |
SW480 |
Homo sapiens |
|
|
|
